Lentigo: Clinical Trials

4 trials for Lentigo, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated, 1 completed, 1 withdrawn. 4 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 24Terminated 2, Completed 1, Withdrawn 1
Phase 11Terminated 1

Follow Lentigo: new trials by email Literature Review of Lentigo trials Research Report on Lentigo

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of Everolimus in the Treatment of Advanced Malignancies in Patients With Peutz-Jeghers Syndrome
Everolimus - Peutz-Jeghers Syndrome, Neoplastic Processes
Phase 2WithdrawnAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)2010-10-012015-04-22
Pilot Study of mTOR Inhibitor Therapy in Peutz-Jeghers Syndrome
Everolimus - Peutz-Jeghers Syndrome
Phase 2TerminatedUniversity of Utah32008-11-012024-09-19
Solar Lentigines Treatment With the Triple Combination Cream
Triple combination cream, Tretinoin 0.05% - Lentigo
Phase 2CompletedPontificia Universidad Catolica de Chile222008-08-012009-09-11
Secretin (ChiRhoStim) Pancreas Perfusion for Pancreatic Adenocarcinoma
Synthetic Human Secretin - Pancreatic Cancer
Phase 1 / Phase 2TerminatedMayo Clinic42006-11-012013-06-24

Narrower conditions

Peutz-Jeghers Syndrome (3)  ·  Neoplasms (2)  ·  Diabetes Mellitus (1)  ·  Neoplasm Metastasis (1)  ·  Neoplastic Processes (1)  ·  Pancreatic Neoplasms (1)  ·  Polyps (1)

Broader conditions

Hyperpigmentation (4)  ·  Melanosis (4)  ·  Pigmentation Disorders (4)  ·  Skin Diseases (4)  ·  Skin and Connective Tissue Diseases (4)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3)  ·  Digestive System Diseases (3)  ·  Gastrointestinal Diseases (3)  ·  Genetic Diseases, Inborn (3)  ·  Intestinal Diseases (3)  ·  Intestinal Polyposis (3)  ·  Neoplastic Syndromes, Hereditary (3)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Digestive System Neoplasms (1)

Interventions

Everolimus (2)  ·  Secretin (1)

Sponsors

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1)  ·  Mayo Clinic (1)  ·  Pontificia Universidad Catolica de Chile (1)  ·  University of Utah (1)

Countries

United States (2)  ·  Chile (1)  ·  Netherlands (1)

Top investigators

Emilia M Zegpi, MD (1)  ·  Heinz-Josef Klumpen, MD (1)  ·  Naoki Takahashi, M.D. (1)  ·  Randall W Burt, MD (1)  ·  Scott Kuwada, MD (1)  ·  William A Romero, MD (1)

Results publications

PMID 16631967, PMID 29371475